DE69227380D1 - Verfahren zur bestimmung und behandlung von alzheimer-krankheit - Google Patents
Verfahren zur bestimmung und behandlung von alzheimer-krankheitInfo
- Publication number
- DE69227380D1 DE69227380D1 DE69227380T DE69227380T DE69227380D1 DE 69227380 D1 DE69227380 D1 DE 69227380D1 DE 69227380 T DE69227380 T DE 69227380T DE 69227380 T DE69227380 T DE 69227380T DE 69227380 D1 DE69227380 D1 DE 69227380D1
- Authority
- DE
- Germany
- Prior art keywords
- determining
- alzheimer disease
- treating alzheimer
- treating
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU9438/91 | 1991-11-12 | ||
AUPK943891 | 1991-11-12 | ||
AUPL337492 | 1992-07-08 | ||
AU3374/92 | 1992-07-08 | ||
PCT/AU1992/000610 WO1993010459A1 (en) | 1991-11-12 | 1992-11-12 | A method for assaying and treating alzheimer's disease |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69227380D1 true DE69227380D1 (de) | 1998-11-26 |
DE69227380T2 DE69227380T2 (de) | 1999-04-08 |
DE69227380T3 DE69227380T3 (de) | 2007-01-11 |
Family
ID=25644152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69227380T Expired - Lifetime DE69227380T3 (de) | 1991-11-12 | 1992-11-12 | Verfahren zur bestimmung und behandlung von alzheimer-krankheit |
Country Status (7)
Country | Link |
---|---|
US (2) | US5705401A (de) |
EP (1) | EP0613560B2 (de) |
JP (1) | JP3277211B2 (de) |
AU (1) | AU669493B2 (de) |
CA (1) | CA2123211C (de) |
DE (1) | DE69227380T3 (de) |
WO (1) | WO1993010459A1 (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010459A1 (en) * | 1991-11-12 | 1993-05-27 | The University Of Melbourne | A method for assaying and treating alzheimer's disease |
US20040208875A1 (en) | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
JP3666818B2 (ja) * | 1993-03-29 | 2005-06-29 | クイーンズ ユニバーシティ アット キングストン | アミロイド症の治療法 |
US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
DE19518845A1 (de) * | 1995-05-23 | 1996-11-28 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure |
JPH0925234A (ja) * | 1995-07-12 | 1997-01-28 | Wakunaga Pharmaceut Co Ltd | 脳疾患改善剤 |
AU6887996A (en) * | 1995-09-01 | 1997-04-01 | Washington University School Of Medicine | Method of reducing neurotoxic injury with zinc chelators |
IL115465A0 (en) * | 1995-09-29 | 1995-12-31 | Yeda Res & Dev | Assay for the diagnosis of dementia |
AUPN649395A0 (en) * | 1995-11-10 | 1995-12-07 | Ramsay Health Care Pty Ltd | A method for diagnosing alzheimer's disease |
GB9610829D0 (en) * | 1996-05-23 | 1996-07-31 | Medical Res Council | Screening of agents for treatment of azlheimers disease |
AU720643B2 (en) * | 1996-08-13 | 2000-06-08 | P.N. Gerolymatos S.A. | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of Alzheimer's disease |
US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
JP2001514661A (ja) * | 1997-03-11 | 2001-09-11 | ザ ジェネラル ホスピタル コーポレイション | アルツハイマー病の処置における使用のための薬剤の同定 |
HUP0004331A3 (en) | 1997-08-21 | 2001-09-28 | Gerolymatos P N Sa | Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it |
US5980914A (en) * | 1997-08-22 | 1999-11-09 | P.N. Gerolymatos S.A. | Clioquinol for the treatment of Parkinson's disease |
US5994323A (en) * | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
AU3068899A (en) | 1998-03-05 | 1999-09-20 | Board Of Regents, The University Of Texas System | Diagnostic assay for late-onset alzheimer's disease |
US20020025944A1 (en) * | 2000-04-28 | 2002-02-28 | Bush Ashley I. | Use of clioquinol for the therapy of Alzheimer's disease |
US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
US20050112543A1 (en) * | 1998-03-11 | 2005-05-26 | The General Hospital Corporation | Method of screening for drugs useful in treating Alzheimer's disease |
US6323218B1 (en) | 1998-03-11 | 2001-11-27 | The General Hospital Corporation | Agents for use in the treatment of Alzheimer's disease |
SI1140090T1 (en) | 1999-01-07 | 2005-06-30 | P.N. Gerolymatos S.A. | Use of phanquinone for the treatment or prevention of memory impairment |
DE19909357A1 (de) * | 1999-03-03 | 2000-09-07 | Gerd Multhaup | Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt |
US6087118A (en) * | 1999-03-04 | 2000-07-11 | Bristol-Myers Squibb Company | Method for diagnosing alzheimer's disease |
US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US6608042B2 (en) * | 2000-03-28 | 2003-08-19 | Aventis Pharma, S.A. | Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof |
WO2002005634A2 (en) | 2000-07-13 | 2002-01-24 | University Of South Florida | Transgenic animal and methods |
US20020172676A1 (en) * | 2001-05-16 | 2002-11-21 | George Jackowski | Method of treatment of alzheimer's disease and device therefor |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
US7517868B2 (en) * | 2004-07-19 | 2009-04-14 | Ip-6 Research Inc | Phytic citrate compounds and process for preparing the same |
CA2592320C (en) | 2004-12-22 | 2015-11-24 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
DE102005037298A1 (de) * | 2005-08-08 | 2007-03-08 | Christine Jaschek | Verwendung von Kalium-, Magnesium-, Calcium- und Zink-Elektrolyten zur Behandlung des Elementemangel- und Austrocknungssyndroms Alzheimer und anderer Demenzen |
PL1954718T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał |
WO2007064972A2 (en) | 2005-11-30 | 2007-06-07 | Abbott Laboratories | Monoclonal antibodies against amyloid beta protein and uses thereof |
RU2015111675A (ru) | 2005-12-12 | 2015-08-10 | Ац Иммуне Са | Специфические в отношении амилоида бета (а бета) 1-42 моноклональные антитела, обладающие терапевтическими свойствами |
ES2352801T3 (es) | 2005-12-22 | 2011-02-23 | Kiacta Sàrl | Tratamiento de nefropatía diabética. |
SG173385A1 (en) * | 2006-07-14 | 2011-08-29 | Ac Immune S A Ch | Humanized antibody against amyloid beta |
LT3851447T (lt) | 2006-10-12 | 2023-12-27 | Bellus Health Inc. | Metodai, junginiai, kompozicijos ir transporteriai, skirti 3- amino-1- propansulfonrūgšties pristatymui |
US8455626B2 (en) * | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
CA2671903A1 (en) * | 2006-12-22 | 2008-07-03 | Genentech, Inc. | Dr6 antagonists and uses thereof in treating neurological disorders |
EP2124952A2 (de) * | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Verfahren zur behandlung von amyloidosen |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
JP2010530744A (ja) * | 2007-06-12 | 2010-09-16 | エーシー イミューン ソシエテ アノニム | アミロイドβに対するヒト化抗体 |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
CN101998863B (zh) * | 2007-10-05 | 2015-09-16 | 基因技术公司 | 抗淀粉状蛋白β抗体在眼病中的用途 |
ES2445590T3 (es) * | 2007-10-05 | 2014-03-04 | Genentech, Inc. | Uso de anticuerpo anti-amiloide beta en enfermedades oculares |
US20110223630A1 (en) * | 2008-06-12 | 2011-09-15 | Anatoly Nikolaev | Method for screening for compounds that inhibit neurodegeneration |
EP2376120A2 (de) | 2008-11-25 | 2011-10-19 | Biogen Idec MA Inc. | Verwendung von dr6- und p75-antagonisten zur förderung des überlebens von zellen des nervensystems |
JP2013510871A (ja) * | 2009-11-12 | 2013-03-28 | ジェネンテック, インコーポレイテッド | 樹状突起棘の密度を促す方法 |
WO2011130377A2 (en) | 2010-04-15 | 2011-10-20 | Abbott Laboratories | Amyloid-beta binding proteins |
NZ606357A (en) | 2010-07-30 | 2015-05-29 | Genentech Inc | Safe and functional humanized anti beta-amyloid antibody |
JP6147665B2 (ja) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | アミロイドベータ結合タンパク質 |
WO2012027794A2 (en) * | 2010-09-01 | 2012-03-08 | The Mental Health Research Institute Of Victoria | Method of treatment and agents useful for same |
US20140302532A1 (en) | 2011-04-12 | 2014-10-09 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury |
WO2012142666A1 (en) * | 2011-04-19 | 2012-10-26 | The Mental Health Research Institute Of Victoria | Method of modulating amine oxidase activity and agents useful for same |
CA2838604C (en) * | 2011-06-08 | 2021-09-28 | Chelation Partners Incorporated | Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism |
WO2015006453A2 (en) * | 2013-07-09 | 2015-01-15 | Mayo Foundation For Medical Education And Research | Pet imaging of zinc transport |
EP3039431A4 (de) * | 2013-08-27 | 2017-05-03 | CRC for Mental Health Ltd. | Verfahren zur identifizierung von biomarkern neurologischer krankheiten und diagnose von neurologischen krankheiten |
EP3761783A4 (de) * | 2018-02-26 | 2021-12-15 | The Trustees of Columbia University in the City of New York | Zinkassoziierte behandlung und diagnose von kachexie |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
US4419365A (en) * | 1981-12-21 | 1983-12-06 | Ciba-Geigy Corporation | Method of treating Alzheimer's disease |
US4847082A (en) * | 1987-01-21 | 1989-07-11 | Robert Sabin | Method of treatment of Alzheimer's disease using phytic acid |
US4837219A (en) * | 1987-11-05 | 1989-06-06 | Jeffrey Hutterer | Medication for Alzheimer's disease |
US4837164A (en) * | 1988-04-27 | 1989-06-06 | Bionix Corporation | Methods for diagonosing, monitoring and controlling the onset and progression of certain dementias and impeding memory loss or improving impairment of memory |
US5234814A (en) * | 1989-06-01 | 1993-08-10 | Du Pont Merck Pharmaceutical Company | Diagnostic assay for alzheimer's disease |
JPH05507470A (ja) * | 1990-04-12 | 1993-10-28 | アクゾ・エヌ・ヴエー | Mca28a32によって認識される抗原ctaa28a32 |
CA2079880A1 (en) * | 1990-04-24 | 1991-10-25 | William E. Van Nostrand | Purification, detection and methods of use of protease nexin-2 |
WO1992000521A1 (en) * | 1990-06-29 | 1992-01-09 | Case Western Reserve University | Diagnostic and prognostic methods based on soluble derivatives of the beta amyloid protein precursor |
EP0546084A4 (en) * | 1990-08-17 | 1994-10-19 | Univ Boston | Proteases causing abnormal degradation of amyloid -g(b)-protein precursor |
JPH04126095A (ja) * | 1990-09-14 | 1992-04-27 | Asahi Chem Ind Co Ltd | 新規モノクローナル抗体及びそれを産生するハイブリドーマ |
EP0568575B2 (de) * | 1991-01-21 | 2010-11-03 | Elan Pharmaceuticals, Inc. | Prüfung und modell für alzheimers-krankheit |
JPH04252955A (ja) * | 1991-01-29 | 1992-09-08 | Asahi Chem Ind Co Ltd | 蛋白質の測定方法、試薬及びキット |
JPH04252956A (ja) * | 1991-01-29 | 1992-09-08 | Asahi Chem Ind Co Ltd | タンパク質の測定方法、試薬及びキット |
JPH04252954A (ja) * | 1991-01-29 | 1992-09-08 | Asahi Chem Ind Co Ltd | タンパクの測定方法、試薬及びキット |
WO1993010459A1 (en) * | 1991-11-12 | 1993-05-27 | The University Of Melbourne | A method for assaying and treating alzheimer's disease |
TW327194B (en) * | 1992-05-01 | 1998-02-21 | American Cyanamid Co | Novel amyloid precursor proteins and methods of using same |
-
1992
- 1992-11-12 WO PCT/AU1992/000610 patent/WO1993010459A1/en active IP Right Grant
- 1992-11-12 US US08/240,720 patent/US5705401A/en not_active Expired - Lifetime
- 1992-11-12 JP JP50882493A patent/JP3277211B2/ja not_active Expired - Fee Related
- 1992-11-12 AU AU29263/92A patent/AU669493B2/en not_active Ceased
- 1992-11-12 EP EP92923431A patent/EP0613560B2/de not_active Expired - Lifetime
- 1992-11-12 CA CA002123211A patent/CA2123211C/en not_active Expired - Fee Related
- 1992-11-12 DE DE69227380T patent/DE69227380T3/de not_active Expired - Lifetime
-
2003
- 2003-11-19 US US10/716,924 patent/US20040265847A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0613560A4 (de) | 1995-05-17 |
US20040265847A1 (en) | 2004-12-30 |
AU669493B2 (en) | 1996-06-13 |
JP3277211B2 (ja) | 2002-04-22 |
WO1993010459A1 (en) | 1993-05-27 |
EP0613560A1 (de) | 1994-09-07 |
DE69227380T2 (de) | 1999-04-08 |
JPH07503316A (ja) | 1995-04-06 |
AU2926392A (en) | 1993-06-15 |
EP0613560B1 (de) | 1998-10-21 |
CA2123211A1 (en) | 1993-05-27 |
EP0613560B2 (de) | 2006-06-21 |
DE69227380T3 (de) | 2007-01-11 |
CA2123211C (en) | 2008-09-16 |
US5705401A (en) | 1998-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69227380T2 (de) | Verfahren zur bestimmung und behandlung von alzheimer-krankheit | |
ATE230606T1 (de) | Verfahren zur vorbeugung und behandlung von allergien | |
DE69838789D1 (de) | Verfahren zur behandlung oder prävention der alzheimerischen krankheit | |
DE696923T1 (de) | Verfahren zur behandlung endo-ostealer materialen | |
DE69112480D1 (de) | Verfahren und Vorrichtung zur Behandlung von medizinischen Abfallstoffen. | |
DE69331469T2 (de) | Verfahren zur behandlung von abfällen | |
DE69218202T2 (de) | Verfahren zur behandlung von fluoroaluminosilikatgläsern | |
DE3888205D1 (de) | Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. | |
DE69222735D1 (de) | Zusammensetzung und Verfahren zur Behandlung von Kühlwasser | |
DE69123519T2 (de) | Verfahren und Vorrichtung zur Bestimmung von Ionen | |
DE69624116D1 (de) | Verfahren zur behandlung von allergischem asthma | |
DE69115921D1 (de) | Verfahren zur behandlung und verwendung von abfallstoffen | |
DE69231592T2 (de) | Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen | |
DE69228054D1 (de) | Orthomolekulares verfahren zur behandlung von sichelzellanämie | |
DE69626311T2 (de) | Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür | |
ATA66096A (de) | Verfahren und vorrichtung zur elektrolytischen behandlung von durchlaufendem gut | |
DE69006509D1 (de) | Verfahren zur behandlung von häuten. | |
DE69429341T2 (de) | Verfahren zur behandlung von flüssigkeiten | |
DE69634207D1 (de) | Verfahren zur behandlung von böden und/oder schüttgütern | |
DE69214139D1 (de) | Verfahren zur behandlung von mit feuchtigkeit enthaltenden feinkohlen | |
ATA171489A (de) | Verfahren zur behandlung von abfallstoffen | |
ATA21789A (de) | Verfahren zur behandlung von abfallstoffen | |
DE69104438T2 (de) | Verfahren zur bestimmung von glukose-6-phosphat und zusammensetzung dafür. | |
ATA315888A (de) | Verfahren zur behandlung von abfallstoffen | |
DE68911922T2 (de) | Vorrichtung und verfahren zur behandlung von bodenbelägen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PRANA BIOTECHNOLOGY LTD., SOUTH MELBOURNE, VICTORI |
|
8366 | Restricted maintained after opposition proceedings |